Navigating MACRA: Quality Reporting for MIPS and OCM - Archive

About Flatiron Health

Flatiron Health helps the oncology community deliver better, more efficient care by powering an oncology software platform to address today’s healthcare challenges.

Backed by Google Ventures, First Round Capital, Roche and others, Flatiron's oncology-specific technology platform delivers comprehensive support for cancer care providers and life science companies. For more information, please visit www.flatiron.com.

Navigating MACRA: Quality Reporting for MIPS and OCM - Archive

On October 14, CMS announced that they finalized the Quality Payment Program as a result of the ruling for Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). This includes the Merit-based Incentive Payment System (MIPS) and Advanced Alternative Payment Models (Advanced APMs).

However, ambiguity still exists around quality reporting, how reimbursement will work in these new models, and what a practice can be doing today with data analytics and technology to succeed.

To help you navigate this new world of alternative payment models, hear from various industry experts on the Quality Payment Program, its potential impact for community oncology and what you can be doing today to prepare.

Watch the Webinar

Panelists:


Michael Kolodziej, MD
Michael Kolodziej, MD
National Medical Director, Managed Care Strategy
Flatiron Health
Brenton Fargnoli, MD
Brenton Fargnoli, MD
Director, Product Marketing & Strategy
and Medical Director, Value-based Care
Flatiron Health
Barry Russo
Barry Russo
CEO
The Center for Cancer and Blood Disorders
Caitlin Sweany
Caitlin Sweany
Director, Transformation
Evolent Health

Moderated By:


Don Sharpe
Don Sharpe
President
OBR